Clinical Trials
Bladder Cancer Trials
- Other Urinary, Urinary BladderPhase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based ImmunotherapyPrincipal Investigator: Daniel P. Petrylak
- Urinary BladderA Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)Principal Investigator: Daniel P. Petrylak
Prostate Cancer Trials
- Other Male Genital, ProstateCustomized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)Principal Investigator: Sandeep Arora
- ProstateSIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate CancerPrincipal Investigator: Isaac Y. Kim
- ProstateProstate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)Principal Investigator: Michael Hurwitz
- ProstatePhase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)Principal Investigator: Michael Hurwitz
Kidney Cancer Trials
- KidneyPhase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell CarcinomaPrincipal Investigator: Kimberly L. Johung
- Kidney, Melanoma, skinA Multicenter Phase 2 Trial to Evaluate Intracranial Response to Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma Who Are Anti-PD1/PD-L1 ExperiencedPrincipal Investigator: Harriet Kluger
- Kidney, Melanoma, SkinXTX301 in Patients With Advanced Solid Tumors
Kidney & Urinary Tract Trials
- Diseases of the Kidney & Urinary TractA Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD)Principal Investigator: Jeffrey Turner
- Children's Health, Diseases of the Kidney & Urinary TractComparison of smart bedwetting alarm vs standard bedwetting alarm
- Diseases of the Kidney & Urinary TractTreating Kidney Disease in Patients with APOL1
All Urology Trials
- KidneyPhase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell CarcinomaPrincipal Investigator: Kimberly L. Johung
- Kidney, Melanoma, skinA Multicenter Phase 2 Trial to Evaluate Intracranial Response to Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma Who Are Anti-PD1/PD-L1 ExperiencedPrincipal Investigator: Harriet Kluger
- Diseases of the Kidney & Urinary TractA Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD)Principal Investigator: Jeffrey Turner
- Other Male Genital, ProstateCustomized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)Principal Investigator: Sandeep Arora
- ProstateSIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate CancerPrincipal Investigator: Isaac Y. Kim